Las Vegas, NV -- (SBWIRE) -- 10/11/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Idenix Pharmaceuticals Inc (NASDAQ:IDIX) ,Grupo Financiero Galicia S.A. (ADR) (NASDAQ:GGAL), Vishay Intertechnology (NYSE:VSH), Merrimack Pharmaceuticals Inc (NASDAQ:MACK).
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) managed to keep its gain at 0.27% on traded volume of 1.16 million shares. The stock settled at $3.66 after floating in a range of $3.65 to $3.80. After recent close, it has reached market capitalization of $490.30 million. Its 52-week range has been $3.15 to $5.93. Idenix Pharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, engages in the discovery and development of drugs for the treatment of human viral diseases in the United States and France.
Will IDIX Continue To Move Higher? Find Out Here
Grupo Financiero Galicia S.A. (ADR) (NASDAQ:GGAL) traded up on a volume of 1.16 million, higher than its standard daily volume. Shares have gained 5.71% to $10.36. Over the last twelve months the stock has added 75% and faced a worst price of $9.98. Grupo Financiero Galicia S.A. operates as a financial services holding company in Argentina.
Will GGAL Continue To Move Higher? Find Out Here
Vishay Intertechnology (NYSE:VSH) settled 2.25% higher at $12.72 on traded volume of 1.15 million shares during the last trading day, while its average trading volume remained 1.14 million shares. The stock has its 12-month low at $8.21 and 52-week high price was $15.39. It traded in a range of $12.56 to $12.72 during the last trading day.Vishay Intertechnology Inc. designs, manufactures, and supplies discrete semiconductors and passive components. The company operates in five segments: MOSFETs, Diodes, Optoelectronic Components, Resistors & Inductors, and Capacitors.
Will VSH Continue To Move Higher? Find Out Here
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) saw its price gain on traded volume as 1.15 million shares changed hands when compared with its average daily volume of 1.14 million shares. The stock was up 2.25% to $12.72. It has gained over the last 12 months, increasing 32.36% and marked new low $8.21. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States.
Will MACK Continue To Move Higher? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)